Accurate Diagnosis and Personalized Treatment of NSCLC for the Interdisciplinary Team
It is essential that all members of the NSCLC care team understand the necessary processes and are equipped to apply current research on genomic targets to testing for mutations/drivers in appropriate advanced NSCLC patients.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy
The goal of this activity is to improve the competence and performance of learners to apply practice-changing clinical data and expert recommendations to optimize the use current/emerging therapeutic strategies in the care of their patients with CLL/SLL. 
Category
  • Chronic Lymphocytic Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Pharmacy Updates: Best Practices for Transitioning Oncology Therapies from the Inpatient to the Outpatient Setting
It is important for pharmacists to be familiar with the steps that are involved in transitioning oncology therapies that have been historically provided in an inpatient setting to the outpatient setting, and be familiar with the criteria for successful implementation of such an initiative.
Category
  • Best Practices
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Event date September 17, 2021
Monthly Oncology Tumor Boards: Systemic Therapy Selection in Metastatic Castration-Resistant Prostate Cancer
The selection of systemic treatments in various lines of therapy for patients with metastatic castration-resistant prostate cancer (CRPC) has become more and more complicated over the last several years. Clinicians who work with patients with metastatic CRPC need to be educated on these updates so that they can help their patients make optimal treatment choices across lines of therapy.
Category
  • Prostate Cancer
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Event date July 21, 2021
NCCN Pharmacy Updates: Palliative Care for Patients with Cancer
Pharmacists can play a critical role in patient education, therapy recommendations, and therapy management in palliative care and should be familiar with appropriate pharmacologic interventions for symptom management.
Category
  • Palliative Care
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Event date August 27, 2021
NCCN Guidelines® Insights - Breast Cancer, Version 4.2021
These NCCN Guidelines Insights focus on the most recent updates to recommendations for adjuvant systemic therapy in patients with nonmetastatic, early-stage, hormone receptor–positive, HER2-negative breast cancer.
Category
  • Breast Cancer
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Cultivating Nursing Resilience during a Pandemic
Current practices that foster nursing resilience need to be evaluated, recognized, enhanced and supported by management and institutional leadership.  Protocols need to be put in place to ensure that nursing and other health care staff have access to support and resources needed to persevere through this challenging time.​​​​​​​
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Patient-Reported Outcomes: Assessment and Interventions to Improve Symptom Management
Early identification of patients’ interventional needs may decrease their morbidity and mortality, increase quality of life, improve patient-clinician communication, and decrease health care utilization and associated costs.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Evolution of CAR T-Cell Therapy
CAR T-cell therapy represents a novel class of immunotherapy and its use has been expanding in relapsed or refractory hematologic malignancies. To ensure optimal patient outcomes, treatment-related toxicities must be closely monitored and quickly managed.
Category
  • Acute Lymphoblastic Leukemia
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Keeping up with the Molecular Targets in the Treatment of Advanced Non-Small Cell Lung Cancer
Nurses and other health care providers need to be familiar with the new approved agents (and their corresponding molecular biomarkers) and side effects associated with the newer agents, so they can improve care for their patients.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation

Pages